Cargando…
Exploring the past, present, and future of postoperative radiotherapy for N2 stage non-small cell lung cancer
Despite conventionally applied postoperative radiotherapy (PORT) in pathological N2 (pN2) stage non-small cell lung cancer (NSCLC) considering high locoregional recurrence, its survival benefit has been a continuous topic of debate. Although several randomized clinical trials have been conducted, ma...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society for Radiation Oncology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556840/ https://www.ncbi.nlm.nih.gov/pubmed/37793623 http://dx.doi.org/10.3857/roj.2023.00430 |